De-escalating Chemotherapy for Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Step Toward Improved Treatment of a Rare Virus-Associated Cancer.

IF 22.5 1区医学 Q1 ONCOLOGY JAMA Oncology Pub Date : 2022-06-16 DOI:10.1001/jamaoncol.2022.1713

K. Lurain, T. Uldrick

引用次数: 1

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

晚期结外自然杀伤/ t细胞淋巴瘤的降糖化疗:一种罕见病毒相关癌症的改进治疗方法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.

期刊最新文献

A Values Proposition for Cancer Care Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer Regulatory Fate of Cancer Indications in the European Union After Accelerated Approval in the US